News

Garber Announces Advisory Committee for Harvard Law School Dean Search

News

First Harvard Prize Book in Kosovo Established by Harvard Alumni

News

Ryan Murdock ’25 Remembered as Dedicated Advocate and Caring Friend

News

Harvard Faculty Appeal Temporary Suspensions From Widener Library

News

Man Who Managed Clients for High-End Cambridge Brothel Network Pleads Guilty

Battling AIDS: One Graduate's Story

By Joe Mathews

On February 18, the New York Times reported an amazing discover. Yung-Kang Chow, a fourth-year M.D./Ph.D student at Harvard Medical School, discovered a new approach to combatting HIV-1, the most common form of the AIDS virus. Chow found he could prevent the virus from duplicating and spreading through a new technique he called "convergent combination therapy." His method uses three different drugs to render the AIDS virus incapable or reproduction. In the laboratory, Chow was able to overpower the virus.

Last week, the Department of Health and Human Services announced it would begin testing Chow's new therapy this spring at 10 sites, including Harvard. But all this wasn't soon enough for one patient.

On February 20--two days after the announcement of Chow's finding--Robert A. Rafsky '68 died of AIDS-related complications at New York University Hospital. He was 47, and would have been invited to his 25th Harvard reunion this spring.

For most of those 47 years, Rafsky led a life many Harvard students could expect. Originally from Philadelphia, Rafsky enrolled in the fall of 1963, lived in Wigglesworth, volunteered at the Loeb Drama Center and did little schoolwork. In fact, he did less schoolwork than most, and was expelled.

He was readmitted in 1964, and this time he did enough work to stay. He also got elected to The Crimson, and became its managing editor.

Rafsky left Harvard in 1968. He tried teaching, but eventually settled on jobs that earned him a more comfortable living. He worked in public relations in New York. He got married and had a daughter, Sara. But in 1985, he came out of the closet and divorced his wife. Sometime, probably in 1987, he contracted AIDS.

It didn't take long for Rafsky to become involved in the AIDS cause. In 1987, he joined ACT-UP. His background in public relations, his working knowledge of the media, even his long hours of experience at The Crimson made him an asset to the group.

"My then-lover, who learned he was HIV-positive at about the same time I did, dragged me to an ACT-UP meeting," Rafsky wrote last November in Queer World. "I found myself using my knowledge of the media to help them get recognition."

But no matter how much progress ACT-UP made, nothing moved fast enough for Rafsky. He soon became a hero of the cause. He worked his way onto 60 Minutes, where CBS reporter Ed Bradley followed him into a ACT-UP protest at a Japanese pharmaceuticals plant in Fort Lee, New Jersey.

He said the pharmaceuticals company, and others like it, were taking too long to develop drugs to treat AIDS. He called one employee of the plant a "murderer" as the worker left the facility. It made for great TV.

"If he's going to stay where he is with power over my life and do nothing and go home every day and eat dinner and think he's fine human being. I'm going to call him a murderer, and I do have the right," Rafsky said when Bradley questioned his tactics. "The problem is that if everybody does business as usual, goes through all the regular routine processes of their day-to-day life, we will all die."

Confront everyone, make noise, take your case to the Village Voice and the New York Times. This, Rafsky believed, was the way to eventually find a cure for AIDS.

Last year, Rafsky found the ultimate opportunity to use his strategy. The frontrunner for the Democratic presidential nomination, a Southern governor named Bill Clinton, was campaigning desperately to save his political life in the New York primary. Clinton was just the sort of smug, shallow politician a desperate man seeking action hates.

So at a fundraiser for Clinton in midtown Manhattan, Rafsky employed his favorite tool: confrontation, with just a hint of humor. And he won huge media coverage.

Rafsky: This is the center of the epidemic. What are you going to do about it?

Clinton: I want to hear what you have to say, I've got friends who are dying of AIDS.

Rafsky: Bill, we're not dying of AIDS as much as we are dying of government neglect.

Clinton: Would you just calm down?

Rafsky: I can't clam down. I'm dying of AIDS while you're just dying of ambition.

After the speech, Clinton moved into the audience to shake Rafsky's hand. As television cameras rolled, Rafsky refused.

Later, in an open letter to Clinton published in Queer World, Rafsky acknowledged that his behavior at the fundraiser involved play-acting--but explained that he felt it was necessary.

"Taking time to imagine the life of a person with AIDS may seem self-indulgent to you," he wrote. "If you don't, though, how will you ever be able to trust your instincts?...Giving speeches that AIDS activists help write and espousing their demands is fine, but rhetoric and vague feelings of sympathy won't be of much use to you in the crucible of making hard decisions."

I'm always nervous about making too much of stories like Rafsky's. Maybe it's because he contracted AIDS through behavior I consider careless and immoral. Or maybe it's because his group, ACT-UP, uses questionable tactics to secure something I oppose--increased funding for AIDS research and treatment.

But sometimes confrontation is necessary. Rafsky realized that. And whether you agree with his specific goals or not, there's a lesson to be learned from both his life and his commitment to the cause.

Rafsky didn't demand more than be deserved. He just wanted someone--anyone--to give the scientific community and the government a kick in the pants. His protests weren't just about AIDS. They were about making the people who call themselves leaders and scientists in this country realize that when you have an epidemic, you don't build consensus--you act boldly and quickly.

Yung-Kang Chow's discovery might have pleased a dying man. But nothing short of a full-fledged cure could have satisfied him.

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags